Magnetic resonance spectroscopy (MRS) [4-10] as well as mass spectrometry [3,10-12] are known to effectively measure 2HG in glioma tissues with good correlations to IDH mutation status. The gene discussed is IDH1; the disease is central nervous system cancer.